218 related articles for article (PubMed ID: 23649071)
1. Imaging modalities in head-and-neck cancer patients.
Sham ME; Nishat S
Indian J Dent Res; 2012; 23(6):819-21. PubMed ID: 23649071
[TBL] [Abstract][Full Text] [Related]
2. Advances in imaging in the work-up of head and neck cancer patients.
de Bree R; Castelijns JA; Hoekstra OS; Leemans CR
Oral Oncol; 2009 Nov; 45(11):930-5. PubMed ID: 19692289
[TBL] [Abstract][Full Text] [Related]
3. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging in the preoperative staging of head and neck squamous cell carcinoma.
Roh JL; Yeo NK; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Oral Oncol; 2007 Oct; 43(9):887-93. PubMed ID: 17207656
[TBL] [Abstract][Full Text] [Related]
4. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
[TBL] [Abstract][Full Text] [Related]
5. Head and neck cancer.
Walden MJ; Aygun N
Semin Roentgenol; 2013 Jan; 48(1):75-86. PubMed ID: 23158052
[TBL] [Abstract][Full Text] [Related]
6. Early prediction of response to chemoradiotherapy for head and neck cancer: reliability of restaging with combined positron emission tomography and computed tomography.
Malone JP; Gerberi MA; Vasireddy S; Hughes LF; Rao K; Shevlin B; Kuhn M; Collette D; Tennenhouse J; Robbins KT
Arch Otolaryngol Head Neck Surg; 2009 Nov; 135(11):1119-25. PubMed ID: 19917925
[TBL] [Abstract][Full Text] [Related]
7. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.
Schmidt GP; Kramer H; Reiser MF; Glaser C
Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383
[TBL] [Abstract][Full Text] [Related]
8. Current use of 18F-fluorodeoxyglucose positron emission tomography and combined positron emission tomography and computed tomography in squamous cell carcinoma of the head and neck.
Zimmer LA; Branstetter BF; Nayak JV; Johnson JT
Laryngoscope; 2005 Nov; 115(11):2029-34. PubMed ID: 16319618
[TBL] [Abstract][Full Text] [Related]
9. Comparison of whole-body PET/CT, dedicated high-resolution head and neck PET/CT, and contrast-enhanced CT in preoperative staging of clinically M0 squamous cell carcinoma of the head and neck.
Rodrigues RS; Bozza FA; Christian PE; Hoffman JM; Butterfield RI; Christensen CR; Heilbrun M; Wiggins RH; Hunt JP; Bentz BG; Hitchcock YJ; Morton KA
J Nucl Med; 2009 Aug; 50(8):1205-13. PubMed ID: 19617339
[TBL] [Abstract][Full Text] [Related]
10. Novel imaging modalities for lymph node imaging in urologic oncology.
Chernyak V
Urol Clin North Am; 2011 Nov; 38(4):471-81, vii. PubMed ID: 22045178
[TBL] [Abstract][Full Text] [Related]
11. Assessment of age-related morphological and functional changes of selected structures of the head and neck by computed tomography, magnetic resonance imaging, and positron emission tomography.
Mahne A; El-Haddad G; Alavi A; Houseni M; Moonis G; Mong A; Hernandez-Pampaloni M; Torigian DA
Semin Nucl Med; 2007 Mar; 37(2):88-102. PubMed ID: 17289457
[TBL] [Abstract][Full Text] [Related]
12. Oncologic PET/MRI, part 1: tumors of the brain, head and neck, chest, abdomen, and pelvis.
Buchbender C; Heusner TA; Lauenstein TC; Bockisch A; Antoch G
J Nucl Med; 2012 Jun; 53(6):928-38. PubMed ID: 22582048
[TBL] [Abstract][Full Text] [Related]
13. Discrepancies and priorities in staging and restaging malignant lymphoma by SPET, SPET/CT, PET/CT and PET/MRI.
Chavdarova LI; Tzonevska AD; Piperkova EN
Hell J Nucl Med; 2013; 16(3):223-9. PubMed ID: 24137584
[TBL] [Abstract][Full Text] [Related]
14. Indications for PET/CT in the head and neck.
Agarwal V; Branstetter BF; Johnson JT
Otolaryngol Clin North Am; 2008 Feb; 41(1):23-49, v. PubMed ID: 18261525
[TBL] [Abstract][Full Text] [Related]
15. Positron emission tomography (PET) in the staging of head neck cancer: comparison between PET and CT.
Bruschini P; Giorgetti A; Bruschini L; Nacci A; Volterrani D; Cosottini M; Ursino F; Mariani G; Fattori B
Acta Otorhinolaryngol Ital; 2003 Dec; 23(6):446-53. PubMed ID: 15198047
[TBL] [Abstract][Full Text] [Related]
16. Imaging to optimally stage lung cancer: conventional modalities and PET/CT.
Truong MT; Munden RF; Movsas B
J Am Coll Radiol; 2004 Dec; 1(12):957-64. PubMed ID: 17411738
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of 18F-FDG PET/CT and CT/MRI with histopathologic correlation in patients undergoing salvage surgery for head and neck squamous cell carcinoma.
Kim SY; Kim JS; Yi JS; Lee JH; Choi SH; Nam SY; Cho KJ; Lee SW; Kim SB; Roh JL
Ann Surg Oncol; 2011 Sep; 18(9):2579-84. PubMed ID: 21409485
[TBL] [Abstract][Full Text] [Related]
18. MRI and PET/CT for triaging stage IB clinically operable cervical cancer to appropriate therapy: decision analysis to assess patient outcomes.
Pandharipande PV; Choy G; del Carmen MG; Gazelle GS; Russell AH; Lee SI
AJR Am J Roentgenol; 2009 Mar; 192(3):802-14. PubMed ID: 19234280
[TBL] [Abstract][Full Text] [Related]
19. [Correlation of FDG-PET and MRI/CT with histopathology in primary diagnosis, lymph node staging and diagnosis of recurrency of head and neck cancer].
Pöpperl G; Lang S; Dagdelen O; Jäger L; Tiling R; Hahn K; Tatsch K
Rofo; 2002 Jun; 174(6):714-20. PubMed ID: 12063600
[TBL] [Abstract][Full Text] [Related]
20. The clinician's expectations from the use of positron emission tomography/computed tomography scanning in untreated and treated head and neck cancer patients.
Fleming AJ; Johansen ME
Curr Opin Otolaryngol Head Neck Surg; 2008 Apr; 16(2):127-34. PubMed ID: 18327031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
